PHGE - BiomX Inc.
6.3
1.430 22.698%
Share volume: 126,138
Last Updated: 03-04-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.44%
PREVIOUS CLOSE
CHG
CHG%
$4.87
1.43
0.29%
View ratios
| Fiscal Date | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 11-14-2024 | 03-25-2025 | 05-15-2025 | 08-13-2025 | 11-12-2025 | 02-19-2026 | |
| Total revenue | 20.643 M | -39.756 M | 908.000 K | 1.428 M | -706.000 K | -4.505 M | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Operating expenses | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Selling general and admin | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Research and development | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total expenses | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Operating income | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Ebit | 9.310 M | -49.163 M | -6.853 M | -6.010 M | -9.247 M | 0.000 | |
| Pretax income | 9.642 M | -14.510 M | -7.658 M | -6.035 M | -9.163 M | -13.336 M | |
| -250.49% | -47.22% | -21.19% | 51.83% | 45.54% | |||
| Income tax | 0.000 | 3.000 K | 1.000 K | 2.000 K | 3.000 K | 1.000 K | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | 9.642 M | -14.513 M | -7.659 M | -6.037 M | -9.166 M | -13.337 M | |
| -250.52% | 47.23% | 21.18% | -51.83% | -45.51% |